Literature DB >> 33663056

Efficacy and safety of polidocanol in the treatment of varicose veins of lower extremities: A protocol for systematic review and meta-analysis.

Nan Li1, Junhai Li, Mei Huang, Xiujun Zhang.   

Abstract

BACKGROUND: The varicose veins of the lower extremities showed earthworm-like dilatation and venous protrusion of the lower extremities. Polidocanol foam sclerotherapy, as a minimally invasive treatment with rapid recovery, less trauma and not easy to relapse, has achieved good results in clinical, but it is lack of evidence-based medicine. The purpose of this study is to evaluate the efficacy and safety of polidocanol in the treatment of varicose veins of the lower extremities by meta-analysis.
METHOD: Chinese National Knowledge Infrastructure, Wanfang Database, Chinese Scientifific Journals Database, China Biology Medicine disc, PubMed, EMBASE database, Web of Science, and Cochrane Library will be used as search sources to conduct for randomized controlled trials of polidocanol in the treatment of varicose veins of lower extremities. The search time is set from the establishment of the database in December 2020 in this study. Two researchers independently extract, delete files, extract data and evaluate the quality. Revman software version 5.3 will be used for statistical analysis of data. RESULT: In this study, the efficacy and safety of polidocanol in the treatment of varicose veins of the lower extremities will be evaluated in terms of total effective rate, incidence of complications and recurrence rate.
CONCLUSION: This study will provide reliable evidence-based evidence for the clinical application of polidocanol in the treatment of varicose veins of lower extremities. ETHICS AND DISSEMINATION: Private information from individuals will not be published. This systematic review also does not involve endangering participant rights. Ethical approval will not be required. The results may be published in a peer-reviewed journal or disseminated at relevant conferences. OSF REGISTRATION NUMBER: DOI 10.17605/OSF.IO/AUR4X.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33663056      PMCID: PMC7909103          DOI: 10.1097/MD.0000000000024500

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  18 in total

1.  A Comparison of Concomitant Tributary Laser Ablation and Foam Sclerotherapy in Patients Undergoing Truncal Endovenous Laser Ablation for Lower Limb Varicose Veins.

Authors:  Ji-Chang Wang; Yan Li; Guang-Yue Li; Yi Xiao; Wei-Ming Li; Qiang Ma; Jian-Lin Liu; Shao-Ying Lu
Journal:  J Vasc Interv Radiol       Date:  2018-04-25       Impact factor: 3.464

2.  Comparison of endovenous ablation techniques, foam sclerotherapy and surgical stripping for great saphenous varicose veins. Extended 5-year follow-up of a RCT.

Authors:  Martin Lawaetz; Julie Serup; Birgit Lawaetz; Lars Bjoern; Allan Blemings; Bo Eklof; Lars Rasmussen
Journal:  Int Angiol       Date:  2017-02-17       Impact factor: 2.789

3.  Recommended reporting standards for endovenous ablation for the treatment of venous insufficiency: joint statement of the American Venous Forum and the Society of Interventional Radiology.

Authors:  Sanjoy Kundu; Fedor Lurie; Steven F Millward; Frank Padberg; Suresh Vedantham; Steven Elias; Neil M Khilnani; William Marston; John F Cardella; Mark H Meissner; Michael C Dalsing; Timothy W I Clark; Robert J Min
Journal:  J Vasc Interv Radiol       Date:  2009-07       Impact factor: 3.464

4.  Detergent sclerosants are deactivated and consumed by circulating blood cells.

Authors:  D E Connor; O Cooley-Andrade; W X Goh; D D F Ma; K Parsi
Journal:  Eur J Vasc Endovasc Surg       Date:  2015-02-14       Impact factor: 7.069

5.  Relationship between patient-reported symptoms, limitations in daily activities, and psychological impact in varicose veins.

Authors:  Rajiv Mallick; Brajesh Kumar Lal; Claire Daugherty
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2017-03

6.  Prevention of excessive endothelin-1 release in sclerotherapy: in vitro and in vivo studies.

Authors:  Alessandro Frullini; Eleonora Da Pozzo; Francesca Felice; Silvia Burchielli; Claudia Martini; Rossella Di Stefano
Journal:  Dermatol Surg       Date:  2014-07       Impact factor: 3.398

7.  Foam sclerotherapy for lower-limb varicose veins: impact on saphenous vein diameter.

Authors:  Rodrigo Gomes de Oliveira; Domingos de Morais Filho; Carlos Alberto Engelhorn; Iruena Moraes Kessler; Felipe Coelho Neto
Journal:  Radiol Bras       Date:  2018 Nov-Dec

8.  A multicenter, randomized, placebo-controlled trial of endovenous thermal ablation with or without polidocanol endovenous microfoam treatment in patients with great saphenous vein incompetence and visible varicosities.

Authors:  Michael Vasquez; Antonios P Gasparis
Journal:  Phlebology       Date:  2016-03-07       Impact factor: 1.740

Review 9.  Latest Innovations in the Treatment of Venous Disease.

Authors:  Robert R Attaran
Journal:  J Clin Med       Date:  2018-04-11       Impact factor: 4.241

Review 10.  Chronic venous insufficiency and varicose veins of the lower extremities.

Authors:  Young Jin Youn; Juyong Lee
Journal:  Korean J Intern Med       Date:  2018-10-26       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.